# OnCo record paper-cabinet-cabozantinib-nejm-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cabinet-cabozantinib-nejm-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cabinet-cabozantinib-nejm-2024" ;
  schema:name "CABINET (Alliance A021602): cabozantinib for advanced neuroendocrine tumours"@en ;
  schema:description "Cabozantinib delayed progression in previously treated advanced neuroendocrine tumours of both pancreatic and extra-pancreatic origin compared with placebo, adding a new option after somatostatin analogues, everolimus or radioligand therapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-cabinet-cabozantinib-nejm-2024/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2403991>, <https://pubmed.ncbi.nlm.nih.gov/39282913/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2403991> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Chan JA, Geyer S, Zemla T, et al." ;
  onco:cancers <https://onco.cc/cancers/lung-net/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:drugs <https://onco.cc/drugs/cabozantinib/> ;
  onco:trials <https://onco.cc/trials/cabinet/> ;
  onco:journals <https://onco.cc/journals/nejm/> .